Companiesandmarkets.com

Global non-small cell lung cancer drugs market: 3% CAGR between 2012 and 2016

Press Release   •   Feb 25, 2013 10:56 GMT

The Global Non-small Cell Lung Cancer market is to grow at a CAGR of 2.77 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Ophthalmic Drugs market has also been witnessing the trend of emergence of personalized medicines. However, the increasing use of complementary and alternative medicine could pose a challenge to the growth of this market.

Personalized medicines have the ability to provide customized treatment to patients. Customized treatment is based on the genetic profile and the medical profile of the patient. Biomarkers help in predicting the patient response to a particular drug. By making use of biomarkers, personalized medicines help identify the patient population set that is more likely to respond to a particular drug therapy. Personalized medicines are increasingly being used in targeted cancer therapies. The major market players are increasingly investing in targeted agents and the development of personalized therapies. In the future, as personalized medicines become reality, the conventional approaches will automatically become obsolete.

One of the key drivers is the increase in the number of people suffering from cancer. Across the globe, the prevalence of cancer is growing at a significant pace. Increased urbanization coupled with sedentary lifestyles has led to an increase in the number of people suffering from cancer. The prevalence of cancer is not only increasing in developed countries, but also in low- and middle-income countries, particularly in India, China, and Japan.

The key vendors dominating the Global Non-small Cell Lung Cancer market are AstraZeneca plc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., and Sanofi S.A. The other vendors mentioned in the report are Bristol-Myers Squibb Co., GlaxoSmithKline Plc., Novartis AG, and OSI Pharmaceuticals Inc.

For more information on the Global non-small cell lung cancer drugs market, please click here: Global non-small cell lung cancer drugs market

For more information on the Healthcare and Medical market, please click here: Healthcare and Medical Reports

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.